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INTRODUCTION
Laparoscopic myomectomy (LM) currently brings more
attention because of increased demands on uterine conserva-
tion and less invasive management of myomas. The advan-
tages of LM are shorter hospitalization, faster recovery, fewer
adhesions, and less blood loss (1). In spite of the increasing
improvements in laparoscopic instruments and techniques,
advanced laparoscopic technical skills are required to perform
LM with success (2). Technical problems inherent to the re-
moval of large uterine myomas include hemostasis, uterine
closure, and removal of the uterine tissue. Furthermore, the
risk of laparoconversion is proportional to the surgeons’ tech-
nical expertise (3-5). To overcome these limitations, minila-
parotomic myomectomy or gasless LM is recommended for
large uterine myomas (6-8). However, LM offers less postop-
erative analgesia and faster postoperative recovery than mini-
laparotomic myomectomy, and the additional instruments
required in gasless LM are not needed in LM (2). To perform
successful LM with the advantages mentioned above, we
developed a new screw for easy pulling and pushing move-
ment, which replaces the conventional screw that is easily
broken. The objective of this study is to verify efficacy and
feasibility of LM for large myomas through the newly-devel-
oped screw and the port placement system that has derived
from the Choi’s 4-trocar method (9).
MATERIALS AND METHODS
A subpopulation of 51 patients whose myomas were 8 cm
or larger in diameter was selected from 155 patients who
underwent LM at Kangbuk Samsung Hospital from July
2003 to November 2006. The size of myoma was confirmed
by ultrasonography prior to the operation. All patients un-
derwent preoperative assessments including detailed medi-
cal history, pelvic examination, gynecologic ultrasonogra-
phy, and Pap smear. All procedures were performed by the
surgeon (the corresponding author) who developed the port
placement system and the new screw (Fig. 1). We reviewed
the clinical charts, and the operative and anesthetic records,
and analyzed the data on the patients’ age, parity, operating
time, diameter of the largest myoma, number of the removed
myomas, hospital stay, change in hemoglobin concentration
from before surgery to postoperative day 1, operative indi-
cations, previous operative history, histopathological reports,
complications, and the pregnancy state after LM. The total
operating time was defined as the time from the insertion of
the first trocar to closure of all port sites. Statistical analysis
was performed by using the findings from SAS program (V
9.1, SAS Institute Inc., NC). Student’s t-test and chi-square
test were used to compare the findings from this study with
those from previous studies. A p value less than .05 was con-
sidered as statistically significant.
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Laparoscopic Myomectomy for Large Myomas
The aim of this study was to assess the feasibility and efficacy of laparoscopic myo-
mectomy (LM) for large myomas. A subpopulation of 51 patients with myomas 8
cm or larger in diameter was selected from 155 patients who underwent LM at Kang-
buk Samsung Hospital from July 2003 to November 2006. The mean age of the
patients was 34.9± ±5.6 yr, mean parity was 0.6± ±0.9, and 8 patients had a previ-
ous operative history. The most common operative indication was a palpable ab-
dominal mass (24 patients, 47%). The mean operating time was 85.6± ±38.9 min,
and the mean diameter of the largest myoma was 9.3± ±1.8 cm. The mean change
in hemoglobin concentration was 2.1± ±1.2 g/dL. Histopathological diagnosis includ-
ed 49 patients of leiomyoma (96.1%) and 2 patients of leiomyoma with adenomyo-
sis (3.9%). Postoperatively, a transfusion was done in 7 patients, and a case of
subcutaneous emphysema was noted. None of the operations was switched to
laparotomy. With the newly-developed screw and the port placement system that
was modified from the Choi’s 4-trocar method to obtain better surgical vision, LM
of large myomas proved to be one of the efficient and feasible methods.
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Operative techniques 
The procedure was performed under general anesthesia
with endotracheal intubation. The patient was placed in a
modified dorsal lithotomy position, a foley catheter was
inserted before a uterine manipulator was fixed on the cervix
to allow uterine manipulation. As shown in Fig. 1A, the
modified Choi’s 4-trocar method was utilized in all opera-
tions during trocar insertion (9). Carbon dioxide was insuf-
flated through the trocar sleeve to create a pneumoperito-
neum, and the intra-abdominal pressure was maintained at
15 mmHg. When surgical preparation was completed, 30
mL of a solution containing 10 IU vasopressin (Vasopressin
�,
Hanlim Pharm, Yongin, Korea) per 100 mL normal saline
was injected into the tissue adjacent to the base and the cap-
sule of the uterine myoma. A vertical incision was made in
the most prominent portion of the uterine myoma to par-
tially remove the capsule of the uterine myoma. Subsequen-
tly, the screw was inserted perpendicularly into the most
prominent part of myoma through the suprapubic 12-mm
trocar. In the next step, the operator held the knob of the
screw in his left hand and operated metzembaum scissors or
grasping forceps with his right hand during dissection of
the myoma. The first assistant, who held a 5-mm telescope
in his left hand and grasping forceps in his right hand, help-
ed the operator dissect the uterine myoma. Traction and
countertraction was applied to the uterine myoma using the
screw with ease. After dissection, the myoma was placed
within a cul-de-sac. A direct vision confirmed any damages
in the uterine endometrium. Approximation and hemosta-
sis of the inner myometrial layers were done using interru-
pted sutures of 1-0 polyglactin 910 (Vicryl
�, Ethicon Inc,
Somerville, NJ, U.S.A.) via an intracorporeal suture techni-
que. For the outer myometrial layer and the serosa, approxi-
mation was done via an extracorporeal suture technique using
interrupted sutures with polyglycolic acid sutures (Lap-su-
ture
�, Sejong Medical, Seoul, Korea) (Fig. 2). After the uterus
was stitched, it was examined to determine the presence of
uterine bleeding. We selectively used bilateral uterine artery
ligation for patients who wanted to preserve their uterus al-
though they did not want future pregnancy. For the purpose
of hemostasis, bipolar coagulator or unipolar coagulator was
not used in the operation, and unipolar coagulator was rarely
used while separating the myoma from a capsule. If there was
no bleeding, a 12-mm diameter trocar was removed. Then,
a morcellator (X-tract Tissue Morcellator
�, Gynecare, Somer-
ville, NJ, U.S.A.) was placed into the abdominal cavity to
enable safe removal of the uterine myoma from the abdomi-
nal cavity. If no further bleeding was present, intraabdomi-
nal irrigation was performed, and the incision site was cov-
ered with an absorbable adhesion barrier (Interceed
�, Gy-
necare, Somerville, NJ, U.S.A.). Although no bleeding was
present at the time, the possibility of delayed bleeding still
existed, and thereby the drain was inserted through 5-mm
trocar and CO2 was eliminated.
RESULTS
The characteristics of patients are summarized in Table 1.
The diameter of the myoma was greater than or equal to 15
cm in 2 cases (15.2 cm and 15.0 cm) and was between 10 cm
and 14 cm in 12 cases. The total number of the resected myo-
mas was 111. With regard to the position of the uterine
myoma, intramural was 46 patients and subserosal was 5
patients. The post-operative results are summarized in Table
2. Combined operations including laparoscopic incidental
appendectomy in 12 patients, ovarian cystectomy in 6 pa-
Fig. 1. (A) Port placement system of laparoscopic myomectomy
for large myomas. (B) New metallic screw.
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tients, and adhesiolysis in 3 patients were done with LM. The
heaviest weight of the remored myoma was 795 gm. Among
the patients who did not want future pregnancy, and was
predicted to have severe bleeding, two patients underwent
laparoscopic bilateral uterine artery ligation. A morcellator
was used to extract the resected myomas from 48 patients.
The posterior culdotomy was performed to safely extract myo-
ma in 3 remaining patients who had previously received
vaginal delivery. The histopathological diagnosis was leiomy-
oma in 49 patients (96.1%) and leiomyoma with adenomyo-
sis in 2 patients (3.9%). For the case of adenomyosis, since
no visible difference was found with leiomyoma, the opera-
tive method was very similar to the operation performed in
the other patients. None of the procedures had to be convert-
ed to laparotomy. There was no intraoperative complication.
Seven patients underwent transfusion both intraoperatively
and postoperatively, of whom six received 2 pints of packed
RBC and one received 4 pints. Because of the low hemog-
lobin value of 8-9 g/dL prior to operation in 3 patients, trans-
fusion was performed regardless of minor bleeding. For one
Fig. 2. (A) Intramural myoma of 9 cm in diameter on the posterior
uterine wall on ultrasonography. (B) An image of a new metallic
screw fixed to the myoma after peeling off the capsule of the myo-
ma. (C) An image of the uterus after laparoscopic myomectomy.
A B
C
Characteristics Mean±S.D.
Age (yr) 34.9±5.6
Parity 0.6±0.9
Diameter of the largest myoma (cm) 9.3±1.8
Indications for LM Number of subjects (n=51) (%)
Palpable abdominal mass 24 (47.0)
Pelvic pain 13 (25.4)
Abnormal uterine bleeding 10 (19.6)
Urinary frequency 4 (7.8)
Previous abdominal surgery
LM, laparoscopic myomectomy.
Number of subjects (n=8) (%)
Cesarean section 4 (37.5)
Appendectomy 2 (25.0)
Laparoscopic tubal sterilization 1 (12.5)
Myomectomy 1 (12.5)
Table 1. Clinical characteristics of laparoscopic myomectomy 
Results Mean±S.D.
Operating time (min) 85.6±38.9
Number of the removed myomas 2.2±1.8
Hospital stay (day) 3.2±0.9
Hemoglobin change (g/dL) 2.1±1.2
Complications Number of subjects (n=8) (%)
Transfusion 7 (13.7)
Subcutaneous emphysema 1 (1.9)
Conversion to laparotomy 0
Table 2. Operative and postoperative dataLaparoscopic Myomectomy 709
patient with seven myomas and 3 patients with larger myo-
mas each with a diameter of 11 cm, 13 cm, and 15 cm, trans-
fusion was performed due to severe bleeding. The case of
myoma with a diameter of 13 cm required 4 pints of trans-
fusion. Subcutaneous emphysema occurred in one patient,
but no further events were noted after conservative treatment.
Three patients became pregnant following LM. Two of these
women gave birth to a healthy baby by cesarean section, and
neither intraabdominal adhesion nor dehiscence was noted
in the operation field. One remaining patient received vagi-
nal delivery and there were no complications such as uterine
rupture. 
DISCUSSION
In recent years, social and cultural changes, and the wide-
spread use of contraceptives have delayed the age of first preg-
nancy. Consequently, uterine preservation is increasingly re-
quested when symptomatic myomas are diagnosed during
the reproductive ages (2). In comparison with abdominal myo-
mectomy (AM), LM provides advantages of shorter hospi-
talization, faster recovery, fewer adhesions, less blood loss,
and better cosmetic effects than AM (1, 10).
The surgical procedure for performing LM of a large uter-
ine myoma consists of three stages. Primarily, surgeons must
obtain the good surgical vision and dissect the myoma away
Reference
No. of    
patients
No. of
myomas
removed/
patient
Operation
time
(min)
Hospital
stay
(hr or
days)
Hb
change
(g/dL) or
blood loss
(mL)
Conver-
sion rate
(%) 
(No.)
No. (%) with complication
Diameter
(mm)
or weight
(gm)
of the largest
myoma
Seracchioli et al. (15) 66 70.1±25.4 2.9±1.5 100.2±38.3 75.6±37.1 1.3±1.2 Subcutaneous emphysema 1 (1.5) 4.3 
(2000) (mm) (hr) (g/dL)
Fever 8 (12.1) (3)
Landi et al. (18) 368 56.9±27.6 2.1 100.8±43.8 2.9±1.3 1.4±0.9 Intraop. complication 12 (3.2) 2.17
(2001) (mm) (days) (g/dL) Intraop. transfusion 10 (2.7) (8)
Postop. complication 21 (5.7)
Transfusion 3 (0.81)
Periumbilical 2 (0.54)
hematoma
Pelvic hematoma 4 (1.08)
→laparoscopy 2 (0.54)
Fever 12 (3.26)
Takeuchi et al. (12) 89 54±23 2.2±1.7 111±40 2.4 102 (mL) Transfusion 1 (1.1) 0
(2003) (mm) (days) Fever 2 (2.2)
Lee et al. (19) 93 71.7±56.4 1.7±1.3 101.1±30.1 3.9±1.2 1.4±0.8 Trocar site bleeding 2 (2.1) 2.1
(2004) (gm) (days) (g/dL) Subcutaneous emphysema 2 (2.1) (2)
Other medical problem 1 (1)
Mettler et al. (20) 178 40±21 - 90 2±0.5 - Abdominal wall hematoma 2 (1.1) 0
(2005) (mm) (days)
Alessandri et al. (2) 74 62±5 2.6±1.0 98±13 38±12 1.1±0.5 Small bowel injury 1 (1.3) 1.3
(2006) (mm) (hr) (g/dL) (1)
Wang et al. (10) 113 199.9±122.4 2.1±2.0 121.5±58.9 2.8±1.0 1.6±0.9 Transfusion 25 (22.1) 0
(2006) (gm) (days) (g/dL) Uterine hematoma 2 (1.7)
Postop. ileus 2 (1.7)
Urinary tract infection 1 (0.85)
Myoma site abscess, oozing
→Laparosopy 1 (0.85)
Malzoni et al. (21) 982 67.2±27.1 2.2 104.5 2.0±0.6 1.1±0.9 Transfusion 4 (0.4) 1.3 
(2006) (mm) (days) (g/dL) Serious complication 3 (0.3) (13)
Temporary kidney failure 1 (0.1)
Bowel perforation 1 (0.1)
Unexpected sarcoma 1 (0.1)
Fever 74 (7.5)
Cystitis 9 (0.9)
Yoon et al. (2007) 51 93±18 2.2±1.8 85.6±38.9 3.2±0.9 2.1±1.2 Transfusion 7 (13.7) 0
(mm) (days) (g/dL) Subcutaneous emphysema 1 (1.9)
Table 3. Summary of previous studies on laparoscopic myomectomy
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from the normal uterine tissue. In patients with a uterine myo-
ma large enough to reach the umbilical level, it has been
suggested that a trocar be positioned superior to the umbili-
cus, the high epigastric port-placement technique (11). How-
ever, there are a few disadvantages, such as the need for 7
trocars and increased cost associated with the high epigas-
tric port-placement technique. Thus we have suggested the
new technique called Choi’s 4-trocar method for LM (9). We
found several advantages of this method. First, the operator
is able to use both hands freely and to improve visibility thro-
ugh 2 trocars placed on either side of the epigastric area on
the upper parallel line from the virtual line drawn horizon-
tally across the umbilicus. If the uterus is too large and it
intercepts the view of the right, the 5-mm telescope can be
replaced into the right trocar, with the other surgical instru-
ments replaced into the umbilical trocar. Thus it is easier to
operate on the right side of the uterus. The minimal direc-
tional changes in the operator’s sight because of the high
lateral trocar, ensure the visibility of the right side, that the
operator does not have to move, and that no more than 4
trocars are required. Secondly, in the Choi’s 4-trocar method,
all trocars are located in the ‘‘safe zone’’ avoiding potential
injury to the ilioinguinal and iliohypogastric nerves and the
inferior epigastric arteries. Third, the risk of injury, the risk
of intestinal herniation, and the scar size are reduced by plac-
ing the telescope into both the right and left 5-mm trocar
ports and by use of only one 12-mm trocar for myoma screw
or morcellator (9). As the effective enucleation of the myoma
is the most crucial step in LM, surgeons must fully extract
the uterine myoma, irrespective of its size or location (12).
Large uterine myomas are difficult to enucleate because they
restrict the amount of space available for pushing and pulling
actions. The softening that accompanies degenerative changes
of the uterine myomas makes it very difficult to perform
maneuvers such as traction-countertraction and insertion
using the conventional myoma screw (13). The convention-
al type of screw has the following disadvantages: 1) it is not
firmly fixed to the myoma; 2) it does not exert sufficient force
during traction and is easily broken while manipulating
large uterine myomas; and 3) it cannot be easily inserted
into soft large uterine myomas that have undergone degen-
erative changes. To overcome the disadvantages of the con-
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Fig. 3. Comparison between this study and the previous studies in myoma size (A), operating time (B), hemoglobin change (C), and ratio
with complication (D). 
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ventional screw, we developed a 10-mm metallic screw. This
screw is effectively designed for easier and stronger fixation
on myoma. Moreover, the connecting part of the former
screw between bolt and shaft that measured only 2.2 mm in
diameter is easily breakable when handling a large myoma,
but the identical size of diameter in the proximal part of a
bolt and a shaft of the new screw reduces the risk of break-
age cohile successfully passing on the force of operator (Fig.
1B). This screw can be fixed firmly to the uterine myoma,
which enables tension to be applied in all directions, facili-
tating extraction of the uterine myoma and shortening the
operating time. The second step of the LM procedure com-
prises the reconstruction of defective area of the uterine myo-
metrium and effective hemostasis. In instances of large defec-
tive areas resulting from surgery of large uterine myomas,
the extracorporeal suture technique enhanced with the intra-
corporeal suture will be more effective for approximation,
hemostasis, and the maintenance of integrity (14). Our expe-
riences have shown the same effect. Finally, to extract the
resected uterine myoma safely outside the abdominal cavity,
posterior colpotomy is done via a vaginal or an abdominal
route using a morcellator.
LM has shown no increase of complications such as uter-
ine rupture than AM (15, 16). Among the tree post-LM
patients who became pregnant in our series, two patients
received cesarean section and one patient received vaginal
delivery, and none of the patients showed any sign of com-
plication.
The first LM was performed by Semm et al. (17). Today,
larger intramural myomas are also enucleated by LM. The
previous studies on LM are summarized in Table 3 (2, 10,
12, 15, 18-21), and our results were compared with the pre-
vious data (Fig. 3). The results using a different unit from
the previous studies and those without standard deviation
were excluded from the analysis. The size of myoma in our
study was larger than in other studies. The mean size of myo-
mas in the previous studies was 61.5 mm, significantly sma-
ller than that in our study (93±18 mm). Our operating
time was shorter than the total mean operating time of the
previous studies. Our study showed a higher Hb change (g/
dL) compared to the total mean value of Hb change in the
previous studies. The mean ratio with complication of our
study was similar to that of the previous studies. Moreover,
the previous studies showed major complications demand-
ing a secondary operation, but our study showed only minor
complications such as subcutaneous emphysema and trans-
fusion. The laparoconversion rate, being 0-4.3% in the pre-
vious studies, was 0% in our study. The size of myoma has
been reported to be in a positive correlation with blood loss,
operating time, and laparoconversion rate (12, 18). Consid-
ering that the myoma size of our study is larger than that of
previous studies, if we performed LM in the circumstance of
the same myoma size, our study could produce even better
results in operating time, complication, and laparoconver-
sion rate with relatively comparable results in the hemoglo-
bin change. In conclusion, the use of the new port placement
system and the newly-developed screw has significantly im-
proved efficiency and feasibility of LM for large myomas.
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